In blood, neurofilament light chain (NfL) shows limited disease specificity,28 with some isolated instances, for example, atypical parkinsonian disorders compared to Parkinson's disease,29 but remains a useful biomarker for general neurodegeneration and acute neurological injury. Here, NEFL is linked to Parkinson disease.